| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |